Delivery Order SPE2DB22D2007-SPE2DB25FJ0ZA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,227.00 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on July 14, 2025, with an ultimate completion date of July 15, 2025. The delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $3,989.52 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, with an ultimate completion date of July 28, 2025. This is a firm fixed price, non-set-aside contract classified as a child award, indicating it derives from a larger contract vehicle. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, valued at $3,636.97. The award, made on August 26, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Corlanor 5 mg tablets (60-count) with a ceiling value of $3,296.56. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Corlanor 5 mg tablets (60-count units) valued at $6,565.56 under a firm fixed-price contract with an ultimate completion date of September 26, 2025. This non-set-aside award was competitively procured and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,664.37 for 60 tablets of Corlanor 5 mg on August 21, 2025, with completion scheduled for August 22, 2025. The contract employs firm fixed pricing and was awarded on a non-set-aside basis through open competition. The award was funded by the Defense Medical Supply Chain, reflecting the federal government's reliance on AmerisourceBergen as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,555.55 on September 24, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 25, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,368.80 for Corlanor 5 mg tablets (60-count units) with a firm fixed price and an ultimate completion date of July 29, 2025. This competitively awarded contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,643.36 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a quantity of 60 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on September 6, 2025, and scheduled for completion by September 8, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Corlanor 5 mg tablets (60-count units) at a ceiling value of $3,437.02. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). Corlanor (ivabradine) is a heart rate-reducing...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ0ZADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,197.68 to AmerisourceBergen Drug Corp for Corlanor 5 mg tablets (60-count) with a completion date of April 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Corlanor (ivabradine) is used in heart failure treatment, demonstrating the company's role in delivering specialized therapeutic medications to federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/24/25 |